Biotech SF
San Francisco Bay Area biotech stories.
Friday, September 7, 2012
Pfizer taps Pleasanton's SFJ Pharma to run late-stage lung cancer trial
SFJ Pharmaceuticals Inc., a Pleasanton-based company formed to run clinical trials for large drug companies, will conduct a Phase III trial of Pfizer Inc.'s experimental lung cancer drug dacomitinib.
Financial terms of the deal were not disclosed, but SFJ said it will fund and supervise the trial across sites in Asia and Europe that will help the world's largest drug maker (NYSE: PFE) submit dacomitinib for regulatory approval.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment